Article
Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates…
medRxiv · 2025 · Pradhan, S.; Dhar, D.; Manna, D.; Chakraborty, S.; Bhattacharyya, A.; Chauhan, K.; Mukherjee, R.; Sen, A.; Pandey, K.; Das, S.; Mukherjee, B.
Key facts
| Title | Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani |
|---|---|
| First author | Pradhan, S.; Dhar, D.; Manna, D.; Chakraborty, S.; Bhattacharyya, A.; Chauhan, K.; Mukherjee, R.; Sen, A.; Pandey, K.; Das, S.; Mukherjee, B. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2024.10.21.619374 |
| Devices mentioned | BK110039, DEN000008, K022086, K040471, K040692, K073490, K100010, K103302 |
| Product codes mentioned | CFN, JCI, JIT, KIT, LBS, NDS, NJT, OOI, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1